For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Map Pharmaceuticals, Inc.

USPTO Granted Patents = 33

% Expired Patents = 27.3

CIPO Patents = 1

EPO Patents = 6

Forward Citations = 312

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Robert Owen Cook (17 out of 23 patents)

Thomas A Armer (16 out of 42 patents)

Jian Zhang (14 out of 23 patents)

4. Stephen B Shrewsbury (5 out of 8 patents)

5. Nabih N Ramadan (5 out of 5 patents)

6. Neil Russell Foster (5 out of 5 patents)

7. Hubert Leonardus Regtop (5 out of 5 patents)

8. Prashant Kakade (4 out of 5 patents)

9. Fariba Dehghani (4 out of 4 patents)

10. Benjamin Stedman (2 out of 2 patents)

11. Darrell Woehler (2 out of 2 patents)

12. John Leonard (2 out of 2 patents)

13. Alfred Sugianto (2 out of 2 patents)

14. Libo Wu (2 out of 2 patents)

15. Donald J Kellerman (1 out of 1 patent)

33 patents: Sort by Forward Citations

1. 10172853 - Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile (2019-01-08),

2. 9833451 - Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile (2017-12-05),

3. 9610415 - Enhanced eductor design (2017-04-04),

4. 9480803 - Dose counter with lockout mechanism (2016-11-01),

5. 9394314 - 8'-hydroxy-dihydroergotamine compounds and compositions (2016-07-19),

6. 9365591 - Fluoroergoline analogs (2016-06-14),

7. 9227030 - Enhanced eductor design (2016-01-05),

8. 9216259 - Methods and apparatus for delivering aerosolized medication (2015-12-22),

9. 9161912 - Inhalation devices and related methods for administration of sedative hypnotic compounds (2015-10-20),

10. 9150593 - Fluoroergoline analogs (2015-10-06),

11. 9012640 - Cabergoline derivatives (2015-04-21),

12. 8969374 - Iso-ergoline derivatives (2015-03-03),

13. 8946420 - Neuromodulatory compounds (2015-02-03),

14. 8933093 - Fluoroergoline analogs (2015-01-13),

15. 8895743 - Methysergide derivatives (2014-11-25),

MAP Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with neurological disorders. With expertise in inhalation technologies, MAP Pharma aims to improve the lives of patients suffering from conditions such as migraine and asthma. Visit their website for more information about their products and research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

33 Patents

#104 in Irvine, CA

#2,453 in California

#10,277 in US

#20,085 in the World

Irvine, CA, United States of America

Map Pharmaceuticals, Inc.

Forward Citations = 312

23 inventors:

Robert Owen Cook (17 out of 23 patents)

Thomas A Armer (16 out of 42 patents)

Jian Zhang (14 out of 23 patents)

4. Stephen B Shrewsbury (5 out of 8 patents)

5. Nabih N Ramadan (5 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…